CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net income	$ 8,213,802	$ 23,583,248
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	8,872,152	9,976,590
Loss on disposal of property and equipment	0	41,782
Provision for doubtful accounts	(1,363,415)	0
Share-based compensation	675,515	1,036,326
Unrealized (gain) loss from investment in equity securities	(14,549)	16,060
Income from equity method investments	891,939	(1,641,837)
Deferred tax	(549,198)	706,813
Changes in operating assets and liabilities, net of business combinations:
Receivable, net	587,637	4,410,363
Receivable, net – related parties	(12,665,493)	(7,234,874)
Other receivables	(11,897,078)	0
Prepaid expenses and other current assets	(2,740,403)	(2,772,749)
Right-of-use assets	1,098,111	0
Other assets	(243,112)	(95,258)
Accounts payable and accrued expenses	3,340,115	(692,000)
Dividends payable	0	617,210
Incentives payable	0	(16,395,926)
Fiduciary accounts payable	260,209	(722,934)
Medical liabilities	(3,818,517)	2,881,017
Income taxes payable	(11,621,861)	(298,439)
Lease liabilities	(1,043,927)	0
Net cash (used in) provided by operating activities	(22,018,073)	13,415,392
Cash flows from investing activities
Payments for business acquisition, net of cash acquired	(41,518,084)	0
Advances on loans receivable	(6,425,000)	(2,500,000)
Purchases of marketable securities	(8,177)	(3,932)
Purchases of investment - equity method	(2,158,000)	(16,673,840)
Purchases of a privately held entity that does not report net asset value per share	0	(405,000)
Purchases of property and equipment	(376,419)	(682,712)
Dividend received	240,000	0
Net cash used in investing activities	(50,245,680)	(20,265,484)
Cash flows from financing activities
Repayment of bank loan	(8,040,257)	(257,374)
Dividends paid	(10,941,588)	(12,000,000)
Change in noncontrolling interest capital	0	27,500
Payment of capital lease obligations	(50,490)	(48,999)
Proceeds from the exercise of stock options and warrants	898,102	2,347,329
Repurchase of shares	(40,000)	0
Borrowings on line of credit	39,600,000	8,000,000
Proceeds from common stock offering	205,000	200,000
Net cash provided by (used in) financing activities	21,630,767	(1,731,544)
Net decrease in cash, cash equivalents and restricted cash	(50,632,986)	(8,581,636)
Cash, cash equivalents and restricted cash, beginning of period	107,636,973	118,500,095
Cash, cash equivalents and restricted cash, end of period	57,003,987	109,918,459
Supplementary disclosures of cash flow information:
Cash paid for income taxes	16,700,000	11,612,590
Cash paid for interest	438,976	144,544
Supplemental disclosures of non-cash investing and financing activities
Cashless exercise of stock options	0	47
Deferred tax liability adjustment to goodwill	8,355,343	1,110,456
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	52,726,305	101,132,237
Restricted cash – short-term - distributions to former NMM shareholders	0	8,040,870
Restricted cash – letters of credit	4,277,682	745,352
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	$ 107,636,973	$ 118,500,095